*-*
HomeFootball ClubsHambourg SVFDA clears GSK’s RSV vaccine for adults ages 50-59

FDA clears GSK’s RSV vaccine for adults ages 50-59

by foot.biz
1 views
FDA clears GSK’s RSV vaccine for adults ages 50-59

The U.S. Food and Drug Administration on Friday approved GSK’s respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the shot’s accessibility to younger patients…
Source : United Press International

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

12345678
............................................................................................................................................+foot